Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Maravai Lifesciences Holdings Inc stock

Learn how to easily invest in Maravai Lifesciences Holdings Inc stock.

Maravai LifeSciences is planning an initial public offering (IPO) to raise up to $1.35 billion. The company is most well known for its mRNA and RNA products, which are used in vaccine development. Most notably, its CleanCap approach is being used in several vaccine trials for COVID-19, though it's too soon to tell if any of those particular vaccines will make it to market.

Here's what we know so far about the IPO, including how to buy in when the stock goes public.

How to buy shares in Maravai Lifesciences Holdings Inc

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MRVI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Maravai Lifesciences Holdings Inc stock price (NASDAQ: MRVI)

Use our graph to track the performance of MRVI stocks over time.

Maravai Lifesciences Holdings Inc shares at a glance

Information last updated 2022-06-24.
Latest market close$29.40
52-week range$23.16 - $63.55
50-day moving average $31.47
200-day moving average $36.58
Wall St. target price$44.00
PE ratio 16.6862
Dividend yield $0 (0%)
Earnings per share (TTM) $1.71

Buy Maravai Lifesciences Holdings Inc shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Maravai Lifesciences Holdings Inc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Maravai Lifesciences Holdings Inc price performance over time

Historical closes compared with the close of $29.4 from 2022-07-01

1 week (2022-06-24) 3.34%
1 month (2022-06-02) -11.87%
3 months (2022-04-01) -16.64%
6 months (2021-12-31) -29.83%
1 year (2021-07-02) -25.13%
2 years (2020-06-28) N/A
3 years (2019-06-28) N/A
5 years (2017-06-28) N/A

Is Maravai Lifesciences Holdings Inc stock undervalued or overvalued?

Valuing Maravai Lifesciences Holdings Inc stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Maravai Lifesciences Holdings Inc's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Maravai Lifesciences Holdings Inc's P/E ratio

Maravai Lifesciences Holdings Inc's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, Maravai Lifesciences Holdings Inc shares trade at around 17x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

However, Maravai Lifesciences Holdings Inc's P/E ratio is best considered in relation to those of others within the biotechnology industry or those of similar companies.

Maravai Lifesciences Holdings Inc's EBITDA

Maravai Lifesciences Holdings Inc's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $652.9 million.

The EBITDA is a measure of a Maravai Lifesciences Holdings Inc's overall financial performance and is widely used to measure a its profitability.

To put Maravai Lifesciences Holdings Inc's EBITDA into context you can compare it against that of similar companies.

Maravai Lifesciences Holdings Inc financials

Revenue TTM $895.3 million
Operating margin TTM 70.03%
Gross profit TTM $658.7 million
Return on assets TTM 23.09%
Return on equity TTM 125.14%
Profit margin 25.22%
Book value $2.91
Market capitalisation $7.3 billion

TTM: trailing 12 months

Maravai Lifesciences Holdings Inc share dividends

We're not expecting Maravai Lifesciences Holdings Inc to pay a dividend over the next 12 months.

You may also wish to consider:

Maravai Lifesciences Holdings Inc overview

Maravai LifeSciences Holdings, Inc. , a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as plasmid DNA and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services.

Frequently asked questions

What percentage of Maravai Lifesciences Holdings Inc is owned by insiders or institutions?
Currently 0.157% of Maravai Lifesciences Holdings Inc shares are held by insiders and 100.026% by institutions.
How many people work for Maravai Lifesciences Holdings Inc?
Latest data suggests 520 work at Maravai Lifesciences Holdings Inc.
When does the fiscal year end for Maravai Lifesciences Holdings Inc?
Maravai Lifesciences Holdings Inc's fiscal year ends in December.
Where is Maravai Lifesciences Holdings Inc based?
Maravai Lifesciences Holdings Inc's address is: 10770 Wateridge Circle, San Diego, CA, United States, 92121
What is Maravai Lifesciences Holdings Inc's ISIN number?
Maravai Lifesciences Holdings Inc's international securities identification number is: US56600D1072

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site